MANILA, Sept 3 (Reuters) – The Philippines’ Food and Drug Administration (FDA) on Friday approved the emergency use of Moderna‘s (MRNA.O) COVID-19 doses for children ages 12 to 17, the agency’s chief said.
“With the Delta variant affecting a lot of children, the experts saw that the benefit of using the vaccine outweigh the risks,” FDA Director General Rolando Enrique Domingo told a public briefing.
Reporting by Neil Jerome Morales
Editing by Shri Navaratnam
Our Standards: The Thomson Reuters Trust Principles.